Published in Nutr Metab (Lond) on September 28, 2009
Training in the fasted state improves glucose tolerance during fat-rich diet. J Physiol (2010) 0.95
Eight week exposure to a high sugar high fat diet results in adiposity gain and alterations in metabolic biomarkers in baboons (Papio hamadryas sp.). Cardiovasc Diabetol (2010) 0.93
Probiotic supplementation prevents high-fat, overfeeding-induced insulin resistance in human subjects. Br J Nutr (2015) 0.88
Significant genotype by diet (G × D) interaction effects on cardiometabolic responses to a pedigree-wide, dietary challenge in vervet monkeys (Chlorocebus aethiops sabaeus). Am J Primatol (2013) 0.87
Acute effects of different diet compositions on skeletal muscle insulin signalling in obese individuals during caloric restriction. Metabolism (2012) 0.86
Eating-related behaviors and appetite during energy imbalance in obese-prone and obese-resistant individuals. Appetite (2013) 0.85
20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway. Mol Endocrinol (2012) 0.84
Propensity to obesity impacts the neuronal response to energy imbalance. Front Behav Neurosci (2015) 0.84
One day of overfeeding impairs nocturnal glucose but not fatty acid homeostasis in overweight men. Obesity (Silver Spring) (2013) 0.80
The effects of energy balance, obesity-proneness and sex on the neuronal response to sweet taste. Behav Brain Res (2014) 0.79
Rapid development of systemic insulin resistance with overeating is not accompanied by robust changes in skeletal muscle glucose and lipid metabolism. Appl Physiol Nutr Metab (2012) 0.79
Endocrine determinants of changes in insulin sensitivity and insulin secretion during a weight cycle in healthy men. PLoS One (2015) 0.76
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature (2004) 12.36
Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA (2004) 11.69
Obesity and insulin resistance. J Clin Invest (2000) 10.47
Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci (1959) 8.62
Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. Lancet (2005) 8.49
RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc Natl Acad Sci U S A (1998) 8.03
Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med (1995) 7.62
Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care (1994) 7.11
Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA (1997) 6.92
Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes (1997) 5.61
Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem (2001) 5.12
Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab (2001) 4.53
Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes (1997) 4.17
Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J (1998) 3.94
How obesity causes diabetes: not a tall tale. Science (2005) 3.89
Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest (1997) 3.66
Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology (2004) 3.50
Retracted Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J Biol Chem (2003) 3.06
Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes (1987) 2.95
Insulin signaling in health and disease. Science (2003) 2.93
Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest (2000) 2.91
Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am J Epidemiol (2004) 2.90
Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase. Nat Genet (1999) 2.81
Regulation of eIF-4E BP1 phosphorylation by mTOR. J Biol Chem (1997) 2.73
Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. J Clin Invest (2002) 2.65
Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro. J Biol Chem (1999) 2.49
Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes (2005) 2.43
Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. Mol Cell Biol (2002) 2.42
Overfeeding rapidly induces leptin and insulin resistance. Diabetes (2001) 2.32
Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism (1996) 2.11
Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J Appl Physiol (1985) (2005) 1.88
Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes (1995) 1.76
Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. Endocrinology (2004) 1.71
Positive and negative regulation of phosphoinositide 3-kinase-dependent signaling pathways by three different gene products of the p85alpha regulatory subunit. Mol Cell Biol (2000) 1.65
Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men. J Physiol (2009) 1.52
Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol (1982) 1.38
Fat and carbohydrate overfeeding in humans: different effects on energy storage. Am J Clin Nutr (1995) 1.37
Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care (2001) 1.29
Response of leptin to short-term and prolonged overfeeding in humans. J Clin Endocrinol Metab (1996) 1.28
Human placental growth hormone increases expression of the p85 regulatory unit of phosphatidylinositol 3-kinase and triggers severe insulin resistance in skeletal muscle. Endocrinology (2003) 1.26
Nutrient sensor links obesity with diabetes risk. Nat Med (2004) 1.19
Loss of hepatic autoregulation after carbohydrate overfeeding in normal man. J Clin Invest (1995) 1.16
Cellular mechanisms of insulin resistance in humans. Am J Cardiol (1999) 1.15
Specific increase in p85alpha expression in response to dexamethasone is associated with inhibition of insulin-like growth factor-I stimulated phosphatidylinositol 3-kinase activity in cultured muscle cells. J Biol Chem (1997) 1.08
In vivo phosphorylation of insulin receptor substrate 1 at serine 789 by a novel serine kinase in insulin-resistant rodents. J Biol Chem (2002) 1.04
Amino acids and leucine allow insulin activation of the PKB/mTOR pathway in normal adipocytes treated with wortmannin and in adipocytes from db/db mice. FASEB J (2004) 1.02
Identification of enhanced serine kinase activity in insulin resistance. J Biol Chem (1999) 1.01
High-fat, low-carbohydrate diet and the etiology of non-insulin-dependent diabetes mellitus: the San Luis Valley Diabetes Study. Am J Epidemiol (1991) 1.01
Assessment of cell-signaling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes. J Cell Biochem (2000) 0.96
Nutritional upregulation of p85alpha expression is an early molecular manifestation of insulin resistance. Diabetologia (2006) 0.93
Short-term, mixed-diet overfeeding in man: no evidence for "luxuskonsumption". Am J Physiol (1985) 0.93
The effects of short-term overfeeding on insulin action in lean and reduced-obese individuals. Metabolism (2006) 0.93
Turning down insulin signaling. J Clin Invest (2001) 0.91
Plasma glucose, insulin, and glucagon before and after long-term overfeeding in identical twins. Metabolism (1995) 0.87
The effects of short-term overfeeding on adipocyte metabolism in Pima Indians. Metabolism (1985) 0.86
Fat feeding decreases insulin responsiveness of adipose tissue lipoprotein lipase. Metabolism (1984) 0.85
Discordance between intramuscular triglyceride and insulin sensitivity in skeletal muscle of Zucker diabetic rats after treatment with fenofibrate and rosiglitazone. Diabetes Obes Metab (2007) 0.83
Effects of Short-Term Dietary Change from High-Carbohydrate Diet to High-Fat Diet on Storage, Utilization, and Fatty Acid Composition of Rat Muscle Triglyceride during Swimming Exercise. J Clin Biochem Nutr (2009) 0.77
Effects of overfeeding on carbohydrate tolerance, insulin secretion, esterification and lipolysis in healthy subjects. Horm Metab Res (1978) 0.76
Assessing adiposity: a scientific statement from the American Heart Association. Circulation (2011) 3.00
Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Clin Cancer Res (2003) 2.11
Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. J Clin Endocrinol Metab (2009) 2.01
Multiple abnormalities of myocardial insulin signaling in a porcine model of diet-induced obesity. Am J Physiol Heart Circ Physiol (2009) 1.68
Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity. J Clin Endocrinol Metab (2009) 1.65
Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem (2001) 1.58
Biology's response to dieting: the impetus for weight regain. Am J Physiol Regul Integr Comp Physiol (2011) 1.53
Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence. Clin Cancer Res (2004) 1.49
Quantitative, spatial resolution of the epigenetic field effect in prostate cancer. Prostate (2008) 1.46
Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr Metab (Lond) (2008) 1.44
Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance. Diabetes (2007) 1.36
Molecular mechanisms of insulin resistance that impact cardiovascular biology. Diabetes (2004) 1.33
Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways. Diabetes (2003) 1.32
New and emerging weight management strategies for busy ambulatory settings: a scientific statement from the American Heart Association endorsed by the Society of Behavioral Medicine. Circulation (2011) 1.27
Human placental growth hormone increases expression of the p85 regulatory unit of phosphatidylinositol 3-kinase and triggers severe insulin resistance in skeletal muscle. Endocrinology (2003) 1.26
Operational research to inform a sub-national surveillance intervention for malaria elimination in Solomon Islands. Malar J (2012) 1.25
Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess. J Biol Chem (2005) 1.22
Insulin sensitivity determines the effectiveness of dietary macronutrient composition on weight loss in obese women. Obes Res (2005) 1.20
Effects of fasting on insulin action and glucose kinetics in lean and obese men and women. Am J Physiol Endocrinol Metab (2007) 1.16
Human placental growth hormone causes severe insulin resistance in transgenic mice. Am J Obstet Gynecol (2002) 1.11
Anticancer antibodies. Am J Clin Pathol (2003) 1.11
Phosphatidylinositol 3-kinase redistribution is associated with skeletal muscle insulin resistance in gestational diabetes mellitus. Diabetes (2002) 1.02
Altered default network activity in obesity. Obesity (Silver Spring) (2011) 1.00
Comparison of 70/30 biphasic insulin with glargine/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy. Nutr Clin Pract (2011) 0.98
Pioglitazone acutely stimulates adiponectin secretion from mouse and human adipocytes via activation of the phosphatidylinositol 3'-kinase. Life Sci (2008) 0.98
Effects of exercise on resting-state default mode and salience network activity in overweight/obese adults. Neuroreport (2013) 0.98
Insulin regulation of sterol regulatory element-binding protein-1 expression in L-6 muscle cells and 3T3 L1 adipocytes. J Biol Chem (2004) 0.97
Brain structure predicts risk for obesity. Appetite (2012) 0.93
Effects of increased meal frequency on fat oxidation and perceived hunger. Obesity (Silver Spring) (2013) 0.92
Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. J Clin Endocrinol Metab (2012) 0.91
Skeletal muscle munc18c and syntaxin 4 in human obesity. Nutr Metab (Lond) (2008) 0.90
Exercise training and calorie restriction increase SREBP-1 expression and intramuscular triglyceride in skeletal muscle. Am J Physiol Endocrinol Metab (2006) 0.89
Insulin attenuates vascular smooth muscle calcification but increases vascular smooth muscle cell phosphate transport. Atherosclerosis (2007) 0.89
Enhanced insulin signaling via Shc in human breast cancer. Metabolism (2003) 0.89
Inhibition of the phosphatidylinositol 3'-kinase signaling pathway leads to decreased insulin-stimulated adiponectin secretion from 3T3-L1 adipocytes. Metabolism (2005) 0.89
Antibody-based therapeutics in oncology. Expert Rev Anticancer Ther (2003) 0.88
Usual breakfast eating habits affect response to breakfast skipping in overweight women. Obesity (Silver Spring) (2015) 0.88
Pilot study of using neutral protamine Hagedorn insulin to counteract the effect of methylprednisolone in hospitalized patients with diabetes. J Hosp Med (2011) 0.87
Effects of chronic hyperinsulinemia in insulin-resistant patients. Curr Diab Rep (2008) 0.87
Acute effects of different diet compositions on skeletal muscle insulin signalling in obese individuals during caloric restriction. Metabolism (2012) 0.86
Eating-related behaviors and appetite during energy imbalance in obese-prone and obese-resistant individuals. Appetite (2013) 0.85
Increasing dietary fat elicits similar changes in fat oxidation and markers of muscle oxidative capacity in lean and obese humans. PLoS One (2012) 0.82
Early growth response gene-1 expression in vascular smooth muscle cells effects of insulin and oxidant stress. Am J Hypertens (2006) 0.81
Intensive control of diabetes in the hospital: why, how, and what is in the future? J Diabetes Sci Technol (2011) 0.80
Knockdown of JNK rescues 3T3-L1 adipocytes from insulin resistance induced by mitochondrial dysfunction. Biochem Biophys Res Commun (2008) 0.80
Garlic extract methylallyl thiosulfinate blocks insulin potentiation of platelet-derived growth factor-stimulated migration of vascular smooth muscle cells. Metabolism (2003) 0.78
Increased farnesylation of p21-Ras and neonatal macrosomia in women with gestational diabetes. J Pediatr (2006) 0.77
Understanding urine testing. Nurs Times (2005) 0.77
Arterial insulin resistance in Yucatan micropigs with diet-induced obesity and metabolic syndrome. J Diabetes Complications (2013) 0.77
IMPACT OF GLUCOSE MANAGEMENT TEAM ON OUTCOMES OF HOSPITALIZARON IN PATIENTS WITH TYPE 2 DIABETES ADMITTED TO THE MEDICAL SERVICE. Endocr Pract (2016) 0.77
Cystic fibrosis-related diabetes in adults: inpatient management of 121 patients during 410 admissions. J Diabetes Sci Technol (2012) 0.76
Update on the NCEP ATP-III emerging cardiometabolic risk factors. BMC Med (2014) 0.76
Transitional care clinic for uninsured and medicaid-covered patients with diabetes mellitus discharged from the hospital: a pilot quality improvement study. Hosp Pract (1995) (2014) 0.75
Do we need to broaden the scope of inpatient diabetes education to include our faculty? Endocr Pract (2015) 0.75
USE OF NPH INSULIN FOR GLUCOCORTICOID-INDUCED HYPERGLYCEMIA. Endocr Pract (2016) 0.75
THE IMPACT OF CARDIOVASCULAR DRUGS ON GLYCEMIC CONTROL: A REVIEW. Endocr Pract (2016) 0.75
Practical approach to management of inpatient hyperglycemia in select patient populations. Hosp Pract (1995) (2013) 0.75